Table 2.
Baseline relationships between imaging and CSF measures
| DMN Deactivation magnitude |
FA in DMN- naWM |
ECN Activation Magnitude |
FA in ECN- naWM |
WMH Volume |
CSF tau/Aβ42 |
|
|---|---|---|---|---|---|---|
| DMN Deactivation magnitude | -- | 0.40 (.025) | −0.48 (.005) | 0.33 (.062) | −0.13 (.494) | −0.39 (.029) |
| FA in DMN-naWM | -- | −0.38 (.032) | 0.91 (.000) | −0.26 (.152) | −0.35 (.047) | |
| ECN Activation Magnitude | -- | −0.40 (.022) | 0.20 (.262) | 0.39 (.026) | ||
| FA in ECN-naWM | -- | −0.22 (.231) | −0.32 (.071) | |||
| WMH Volume | -- | −0.04 (.827) | ||||
| CSF tau/Aβ42 | -- |
Values are Pearson-r with p-values in parentheses. Significant (p < .05) relationships are shown in bold. All analyses had n = 32.